Enhancing Head and Neck Cancer Patients’ Experiences of Survivorship

Phase 3

Active, not recruiting

• Conditions: Mental Health; Survivorship; Cancer; Quality of Life; Chronic disease self-management; Mental Health - Depression; Cancer - Head and neck; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation

• Registration Number: ACTRN12613000542796
• Lead Sponsor: Associate Professor Jane Turner

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-05-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients eligible for this study must have a diagnosis of head and neck cancer and must have undergone treatment at one of the participating sites

*Aged 18 years or over
*Have within the past month completed a defined treatment protocol for cancer of the tongue, mouth, salivary glands. pharynx, the oro-, hypo- and nasopharynx, nasal cavities, middle ear, sinuses or larynx
OR
Within the past month have completed a defined treatment protocol for non-melanoma skin cancers of the head and neck requiring treatment known to cause toxicity (for example, combinations of surgery, radiotherapy or chemotherapy).
*Able to speak and read English
*Physical, cognitive and mental status such that can participate in the study

Exclusion Criteria

*Inability to speak and read English
*Receiving low-toxicity treatment for head and neck cancer (for example laser therapy alone)
*Presence of severe mental, cognitive or physical conditions with would limit the person’s ability to participate in the study, or which require ongoing regular specialist treatment
Advanced disease if life expectancy is considered to be less than 6 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in patient Quality of Life as measured by the Functional Assessment of Cancer Therapy – Head and Neck (FACT–H&N)[Baseline, 3-month and 6-month follow-ups]